About Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals is a company based in Mumbai (India) founded in 2016 by Nikhil Chari. Indiabulls Pharmaceuticals has raised $47.57 million across 2 funding rounds from investors including The Clermont and Indiabestbuy. The company has 340 employees as of April 06, 2024.
- Headquarter Mumbai, India
- Employees 340 as on 06 Apr, 2024
- Founders Nikhil Chari
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indiabulls Pharmaceuticals Limited
- Date of Incorporation 06 Jul, 2016
- Jurisdiction Industrial Complex Dundahera, Haryana, India
-
Annual Revenue
$9.11 M (USD)42.16as on Mar 31, 2022
-
Net Profit
-$9.1 M (USD)14.99as on Mar 31, 2022
-
EBITDA
-$6.4 M (USD)26.81as on Mar 31, 2022
-
Total Equity Funding
$47.57 M (USD)
in 2 rounds
-
Latest Funding Round
$24.02 M (USD), Series A
Nov 11, 2017
-
Investors
The Clermont
& 1 more
-
Employee Count
340
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals has successfully raised a total of $47.57M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $24.02 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Clermont and Indiabestbuy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward Singapore by The Clermont.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Indiabulls Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indiabulls Pharmaceuticals
Investment portfolio details for Indiabulls Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indiabulls Pharmaceuticals
Detailed financials for Indiabulls Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indiabulls Pharmaceuticals Comparisons
Peer comparison for Indiabulls Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indiabulls Pharmaceuticals
Detailed competitors of Indiabulls Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indiabulls Pharmaceuticals
Complete news archive for Indiabulls Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indiabulls Pharmaceuticals
Indiabulls Pharmaceuticals was founded in 2016.
Indiabulls Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Nikhil Chari is the current CEO of Indiabulls Pharmaceuticals. They have also founded this company.
Indiabulls Pharmaceuticals is a funded company, having raised a total of $47.57M across 2 funding rounds to date.
As of Apr 06, 2024, the latest employee count at Indiabulls Pharmaceuticals is 340.
Annual revenue of Indiabulls Pharmaceuticals is $9.11M as on Mar 31, 2022.
Indiabulls Pharmaceuticals was established in 2016 in Mumbai, India, within the pharmaceuticals sector. Generic formulations and medical devices are produced for therapies addressing chronic and acute conditions. Operations rely on a network of GMP-certified manufacturing facilities for sourcing. The portfolio encompasses categories such as respiratory care, cardiometabolic and cardiovascular wellness, womens health care, and additional areas.
Indiabulls Pharmaceuticals has 2 investors. Key investors include The Clermont, and Indiabestbuy.
The valuation of Indiabulls Pharmaceuticals is $275.66M as of Nov 2017.